Shenzhen Hygieia Biotechnology Co., Ltd. focuses on the R & D, production and sales of new dietary supplement raw materials. At present, we achieved the commercial production of NMN through a new enzymatic process.Since 2020, Hygieia has started the Safety Assessment of NMN raw materials, contributing to the compliance, legality and safety verification of NMN. Acute toxicology experiment - Completed, and the result is non-toxic;Bacterial reverse mutation test - In progress Mammalian erythrocyte micronucleus test - In progress In vitro mammalian cell chromosome aberration test - In progress*90 day oral toxicity test in rats - In progress Teratogenicity test in rats - In progressWe not only supply high qualified NMN raw materials, but also provide one-stop service from "Formulation" to "Global Supply chain management of NMN finished product".Now we provide high-quality NMN raw materials and finished products solutions for the global nutrition and health field
Country / Region
China
Province
Guangdong
Business Type
Manufacturer
Main Products
NMN, NAD, Nicotinamide Mononucleotide, Urolithin A, Spermidine
Year Established
2020
Employees
5 - 10 People
Turnover One Year
US$1 Million - US$2.5 Million
Main Markets
North America: 40%
Western Europe: 30%
Eastern Europe: 20%
